title: Pancreatic secretory trypsin inhibitor gene is highly expressed in the liver of adult-onset type II citrullinemia.
abstract: Deficiency of argininosuccinate synthetase (ASS) causes citrullinemia. Type II citrullinemia is found in most patients with adult-onset citrullinemia in Japan, and ASS is deficient specifically in the liver. Previous studies have shown that the decrease of hepatic ASS activity is caused by a decrease in enzyme protein with normal kinetic properties and that there are no apparent abnormalities in the amount, translational activity, and nucleotide sequence of hepatic ASS mRNA. Recent results of homozygosity testing indicate that the primary defect of type II citrullinemia is not within the ASS gene locus. In this present work, to understand the pathogenesis and pathophysiology of type II citrullinemia, we have characterized the alterations of gene expression in the liver of type II patients using the recently developed mRNA differential display method. Some cDNA bands expressed differently in type II citrullinemia patients and control were selected, cloned, and sequenced. Nucleotide sequence analysis and homology searching revealed an interesting clone which has 99% homology with the human pancreatic secretory trypsin inhibitor (hPSTI). Northern blot and RT-PCR analyses showed that the expression of hPSTI mRNA increased significantly in the liver of all type II patients tested. Furthermore, the concentration of hPSTI protein was found to be higher in the liver of type II citrullinemia than in control. These results suggest that hPSTI may be related to the primary defect of type II citrullinemia and may be useful as a diagnostic marker, although the detailed mechanism of the high expression of hPSTI mRNA in type II liver is not yet known.
authors.affiliation: Department of Biochemistry, Faculty of Medicine, Kagoshima University, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Kobayashi
authors.forename: M
authors.initials: M
authors.lastname: Nakata
authors.forename: H
authors.initials: H
authors.lastname: Terazono
authors.forename: T
authors.initials: T
authors.lastname: Shinsato
authors.forename: T
authors.initials: T
authors.lastname: Saheki
mesh_terms: D000592:Amino Acid Metabolism, Inborn Errors / Q000235:genetics* / Q000378:metabolism; D001124:Argininosuccinate Synthase / Q000172:deficiency*; D001483:Base Sequence; D015152:Blotting, Northern; D002956:Citrulline / Q000097:blood*; D017931:DNA Primers; D015870:Gene Expression / Q000235:genetics; D006801:Humans; D008099:Liver / Q000201:enzymology / Q000378:metabolism*; D008969:Molecular Sequence Data; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D014359:Trypsin Inhibitor, Kazal Pancreatic / Q000032:analysis / Q000096:biosynthesis / Q000235:genetics*
chemical_list: D017931:DNA Primers; D012333:RNA, Messenger; D002956:Citrulline; D014359:Trypsin Inhibitor, Kazal Pancreatic; D001124:Argininosuccinate Synthase